S&P affirms CFF leaves DexMA on Watch Negative

The period that S&P allowed issuers to modify their covered bond programmes and meet the agency’s revised swap counterparty criteria came to an end on January 11. Many of the eight programmes that S&P identified, including CFF, have now been affirmed though some, such as DexMA, remain in Watch Negative and others have been downgraded.